SilverSun Technologies Inc
Change company Symbol lookup
Select an option...
SSNT SilverSun Technologies Inc
MDLZ Mondelez International Inc
FE FirstEnergy Corp
CADE Cadence Bancorp
SCHD Schwab U.S. Dividend Equity ETF™
ARKK ARK Innovation ETF
URANF International Prospect Ventures Ltd
QSR Restaurant Brands International Inc
STAF Staffing 360 Solutions Inc
BOKF BOK Financial Corp
Go

Information Technology : Software | Small Cap Blend
Company profile

SilverSun Technologies, Inc. is a business application, technology and consulting company. The Company is engaged in providing strategies and solutions to meet information, technology and business management needs. Its services and technologies enable customers to manage, protect and monetize their enterprise assets in the cloud. It offers solutions for accounting and business management, financial reporting, enterprise resource planning (ERP), warehouse management systems (WMS), human capital management (HCM), customer relationship management (CRM) and business intelligence (BI). The Company has dedicated Information Technology (IT) network services practice that provides managed services, cybersecurity, application hosting, disaster recovery, business continuity, cloud and other services. Its customers are across the United States, with concentrations in the New York/New Jersey metropolitan area, Arizona, Southern California, North Carolina, Washington, Oregon and Illinois.

Closing Price
$6.35
Day's Change
0.11 (1.76%)
Bid
--
Ask
--
B/A Size
--
Day's High
6.38
Day's Low
6.20
Volume
(Light)
Volume:
39,613

10-day average volume:
213,724
39,613

UPDATE: Bionano Genomics prices $200 million underwritten stock offering at a discount of $6 a share

7:59 am ET January 20, 2021 (MarketWatch)
Print

Bionano Genomics Inc. (BNGO) priced a $200 million underwritten stock offering announced late Tuesday (http://www.marketwatch.com/story/bionano-genomics-to-sell-more-shares-stock-falls-2021-01-19)at a discount of $6 a share, selling 33.3 million shares. The stock closed Tuesday at an alltime high of $9.14. The genome sequencing company's shares have gained 662% in the last 12 months on little news flow, and trading volumes have been active in recent sessions. Bionano previously sold 29 million shares at $3.05 a share less than two weeks ago. The stock fell 22% in premarket trade to reflect the dilutive effect of the offering. Oppenheimer was sole bookrunner on the deal with BITG acting as lead manager and Ladenburg Thalmann and Maxim Group acting as co-managers. Underwriters have a 30-day option to purchase another 5 million shares at the offering price. Bionano shares traded for less than $1 for much of 2020, before prices shot higher just before the end of the year despite no public announcements about changes at the genome-analysis company, which lost nearly $30 million on sales of $4.5 million in the first nine months of 2020.

-Ciara Linnane; 415-439-6400; AskNewswires@dowjones.com

	

(END) Dow Jones Newswires

January 20, 2021 07:59 ET (12:59 GMT)

Copyright (c) 2021 Dow Jones & Company, Inc.

Earnings Calendar and Events Data provided by |Terms of Use| © 2021 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2021. All rights reserved.